Exclusive Webinar :Don't miss the latest webinar on Global Investing with Passive Products on June 22, 11am
you are here: HomeNewsBusiness

Buy Biocon; target of Rs 470: Sharekhan

Sharekhan is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 470 in its research report dated January 22, 2021.

February 01, 2021 / 06:36 PM IST
  • bselive
  • nselive
Todays L/H

Sharekhan's research report on Biocon

Q3FY2021 was a weak quarter as COVID-19 disruptions led to procurement and supply chain delays, and also affected Biocon’s planned market expansion initiatives. Biocon sees this as a short-lived phenomenon and expects businesses to regain normalcy by FY2022. Biologics segment is expected to be a critical growth driver and the company is well placed to harness the growth opportunities. Better growth prospects, healthy balance sheet and lower debt-equity augur well for company. Possible listing of subsidiary – Biocon Biologics points towards significant value unlocking potential.


We retain a Buy on Biocon Limited with a revised PT of Rs. 470.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Broker Research
first published: Feb 1, 2021 06:36 pm

stay updated

Get Daily News on your Browser